Literature DB >> 19392906

Factors associated with delay to acyclovir administration in 184 patients with herpes simplex virus encephalitis.

J Poissy1, M Wolff, A Dewilde, F Rozenberg, F Raschilas, M Blas, H Georges, C Chaffaut, Y Yazdanpanah.   

Abstract

The main predictor of outcomes in herpes simplex virus (HSV) encephalitis (HSE) is the delay between hospital admission and initiation of acyclovir. In this study, factors associated with late initiation of acyclovir were identified. The study included adults from northern France whose cerebrospinal fluid (CSF) was positive for HSV by PCR. Late initiation of acyclovir was defined as a delay of >1 day from hospital admission. In total, 184 patients were retrospectively enrolled from January 1991 to December 2002. The median age was 60 years (range: 17-91), and 102 (55.4%) were male. Acyclovir was initiated >1 day after hospital admission in 68 patients (37.0%). According to multivariate analysis, independent risk factors for late initiation of acyclovir were severe underlying disease (Knaus score >or=C) (OR 4.1; 95% CI 1.5-11.7); alcohol abuse (OR 3.4; 95% CI 1.3-8.9); and a delay of >1 day from admission to first brain imaging (OR 8.4; 95% CI 3.9-18.0). In addition, univariate analysis suggested an association between a finding of <10 leukocytes/mm(3) in CSF at admission (OR 2.5; 95% CI 0.7-5.8). These characteristics were found in 26 (14.1%), 23 (12.5%), 66 (35.9%) and 27 (14.7%) patients, respectively. One risk factor was identified in 109 (59.2%) patients, two in 29 (15.8%), and three in six (3.3%). Patients with HSE often present with severe underlying disease, chronic alcohol abuse, or atypical CSF findings, and such factors should not be allowed to delay diagnosis and administration of acyclovir.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19392906     DOI: 10.1111/j.1469-0691.2009.02735.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  28 in total

1.  Efficacy of CMX001 against herpes simplex virus infections in mice and correlations with drug distribution studies.

Authors:  Debra C Quenelle; Bernhardt Lampert; Deborah J Collins; Terri L Rice; George R Painter; Earl R Kern
Journal:  J Infect Dis       Date:  2010-10-05       Impact factor: 5.226

Review 2.  Neuro-intensive care of patients with acute CNS infections.

Authors:  J David Beckham; Kenneth L Tyler
Journal:  Neurotherapeutics       Date:  2012-01       Impact factor: 7.620

3.  Impact of FilmArray meningitis encephalitis panel on HSV testing and empiric acyclovir use in children beyond the neonatal period.

Authors:  Kevin Messacar; James T Gaensbauer; Meghan Birkholz; Claire Palmer; James K Todd; Kenneth L Tyler; Samuel R Dominguez
Journal:  Diagn Microbiol Infect Dis       Date:  2020-05-17       Impact factor: 2.803

Review 4.  Herpes Simplex Virus-1 Encephalitis in Adults: Pathophysiology, Diagnosis, and Management.

Authors:  Michael J Bradshaw; Arun Venkatesan
Journal:  Neurotherapeutics       Date:  2016-07       Impact factor: 7.620

5.  Infectious encephalitis: utility of a rational approach to aetiological diagnosis in daily clinical practice.

Authors:  C López-Sánchez; E Sulleiro; C Bocanegra; S Romero; G Codina; I Sanz; J Esperalba; J Serra; C Pigrau; J Burgos; B Almirante; V Falcó
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-11-25       Impact factor: 3.267

6.  Functional outcomes in adult patients with herpes simplex encephalitis admitted to the ICU: a multicenter cohort study.

Authors:  P Jaquet; E de Montmollin; C Dupuis; C Sazio; M Conrad; V Susset; S Demeret; J M Tadie; L Argaud; F Barbier; B Sarton; R Chabane; D Daubin; N Brulé; N Lerolle; M Alves; D Da Silva; A El Kalioubi; S Silva; P Bailly; M Wolff; L Bouadma; J F Timsit; R Sonneville
Journal:  Intensive Care Med       Date:  2019-07-10       Impact factor: 17.440

Review 7.  Diagnosis and Treatment of Central Nervous System Infections in the Emergency Department.

Authors:  Maia Dorsett; Stephen Y Liang
Journal:  Emerg Med Clin North Am       Date:  2016-11       Impact factor: 2.264

Review 8.  Sepsis and Other Infectious Disease Emergencies in the Elderly.

Authors:  Stephen Y Liang
Journal:  Emerg Med Clin North Am       Date:  2016-08       Impact factor: 2.264

Review 9.  Immunomodulatory Strategies in Herpes Simplex Virus Encephalitis.

Authors:  Jocelyne Piret; Guy Boivin
Journal:  Clin Microbiol Rev       Date:  2020-02-12       Impact factor: 26.132

Review 10.  Recent issues in herpes simplex encephalitis.

Authors:  Peter G E Kennedy; Israel Steiner
Journal:  J Neurovirol       Date:  2013-06-18       Impact factor: 2.643

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.